Concert Genetics Genetic Testing: Aortopathies and Connective Tissue Disorders V1.2024
Customize your policy alerts
Sign up for WellCare Policy 1 alerts
Get alerted when Policy 1 changes without checking for updates manually.
Monitor payer policy activity
This policy governs medical necessity criteria and coding for genetic testing (single-gene, targeted familial variant, and multigene panels) used to diagnose or confirm hereditary aortopathies and connective tissue disorders for WellCare members.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.